Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
McKesson
Boehringer Ingelheim
Baxter
Dow

Last Updated: October 6, 2022

Terbutaline sulfate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for terbutaline sulfate and what is the scope of freedom to operate?

Terbutaline sulfate is the generic ingredient in four branded drugs marketed by Novartis, Sanofi Aventis Us, Pharmacare, Akorn, Chartwell Injectable, Dr Reddys, Fresenius Kabi Usa, Hikma Farmaceutica, United Biomedcl, Ani Pharms, Impax Labs, Lannett Co Inc, and Twi Pharms, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for terbutaline sulfate. Nine suppliers are listed for this compound.

Drug Prices for terbutaline sulfate

See drug prices for terbutaline sulfate

Recent Clinical Trials for terbutaline sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duke HealthPhase 2/Phase 3
Kanecia Zimmerman, MD MPHPhase 2/Phase 3
The Emmes Company, LLCPhase 2/Phase 3

See all terbutaline sulfate clinical trials

Medical Subject Heading (MeSH) Categories for terbutaline sulfate

US Patents and Regulatory Information for terbutaline sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 077152-002 Mar 25, 2005 AB RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lannett Co Inc TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 077152-001 Mar 25, 2005 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Twi Pharms TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 211832-001 Jun 19, 2020 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Twi Pharms TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 211832-002 Jun 19, 2020 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Fresenius Kabi Usa TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 076887-001 May 26, 2004 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sanofi Aventis Us BRICANYL terbutaline sulfate TABLET;ORAL 017618-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for terbutaline sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ani Pharms BRETHINE terbutaline sulfate TABLET;ORAL 017849-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Pharmacare BRETHINE terbutaline sulfate INJECTABLE;INJECTION 018571-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Novartis BRETHAIRE terbutaline sulfate AEROSOL, METERED;INHALATION 018762-001 Aug 17, 1984 See Plans and Pricing See Plans and Pricing
Ani Pharms BRETHINE terbutaline sulfate TABLET;ORAL 017849-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Sanofi Aventis Us BRICANYL terbutaline sulfate TABLET;ORAL 017618-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Ani Pharms BRETHINE terbutaline sulfate TABLET;ORAL 017849-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Boehringer Ingelheim
Colorcon
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.